August 2016

Features

Anti-VEGF Everywhere, But Not a Drop to Use

Reusing Lucentis and Eylea vials might be feasible the authors say.

The Evolution of Vein Occlusion Therapy

Investigators are experimenting with combination therapies that may enhance outcomes.

Treating Wet AMD with Anti-VEGF Drugs

It’s becoming clear that the treat-and-extend protocol works well—and may be needed indefinitely.

Treatment That Fits DME Patients to a ‘T’

Physicians use the results of Protocol T to inform their own treatment protocols.

Departments

Review News

Tecnis Symfony IOL Secures FDA Approval

Ophthalmic Product Development Insights

An Interdisciplinary Approach to Addressing an Unmet Need

Technology Update

Creating Great Surgical Videos (for less money)

Capturing live surgery for simultaneous viewing—or later viewing—can be done in 2-D or 3-D without breaking the bank.

Medicare Q & A

Understanding HEDIS For Ophthalmology

An overview of HEDIS, covering insurance plans and the role of ophthalmologists and optometrists.

Retinal Insider

Targeting VEGF’s Silent Partners in DME

A look at what’s going on behind the scenes in patients for whom anti-VEGF therapy has little or no effect.

Glaucoma Management

MIGS & Meds: Refining Trabecular Bypass

Implanting a MIGS device and adding one drop may be a much better option for many glaucoma patients than a trab or tube.

Therapeutic Topics

How Do You Quantify The Qualitative?

Refractive Surgery

Tips for Pre-LASIK Resurfacing

Doing your prep work ahead of time will make things smoother in the long run, surgeons say.

Research Review

LUNAR Glaucoma Study Results

Wills Eye Resident Case Series

August 2016 Wills Eye Resident Case Series

A patient with cancer and various sequelae also seeks treatment for three months of blurred vision.

Current Issue